<DOC>
	<DOC>NCT01113229</DOC>
	<brief_summary>To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.</brief_summary>
	<brief_title>Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage</brief_title>
	<detailed_description>Objective : To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks'. Method : Double blinded Randomized controlled trial in two centers over 30 months. Treatment : Patients will be randomly allocated into one of the two following group : Group A : 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two misoprostol tablets taken orally (400Âµg) following cord clamp. Group B: 10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two placebo tablets taken orally following cord clamp. Number of patients: 1550 patients per group (one third reduction of occurrence with alpha and beta set at 0.05 and 0.20 respectively). Patients were included in the study during 48 hours.</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Women&gt;18 years, during first stage of normal labor, at 36 to 42 weeks, with epidural analgesia and informed signed consent Cesarean section delivery, clotting disorders, prostaglandin allergy, absent consent.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Post Partum Haemorrhage,</keyword>
	<keyword>oxytocin,</keyword>
	<keyword>misoprostol,</keyword>
	<keyword>prevention,</keyword>
	<keyword>delivery.</keyword>
</DOC>